ENANTA PHARMACEUTICALS INC
Datakwaliteit: 100%
ENTA
NASDAQ
Manufacturing
Chemicals
€ 14,21
▲
€ 0,15
(1,07%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-9,43%
Groei
Revenue Growth (5Y)
-9,43%
Onder sectorgemiddelde (1,72%)
Revenue (1Y)-3,42%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-91,15%
Onder sectorgemiddelde (-54,68%)
ROIC-28,20%
Net Margin-111,78%
Op. Margin-115,09%
Veiligheid
Debt / Equity
N/A
Current Ratio4,44
Interest Coverage-8,97
Waardering
PE (TTM|NTM)
-4,30 | -6,59
Onder sectorgemiddelde (-1,49)
P/B Ratio3,19
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -9,43% annually over 5 years
Negative free cash flow of -44,01 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,01%
Price History
Financiële Trends
Koersdoel Analisten
6 analisten
Buy
+30.2%
upside to target
Huidig
€ 14,21
Consensus Target
€ 18,50
€ 12,00
Laag
€ 20,00
Hoog
Vooruitzicht
Forward K/W
-6,59
Forward WPA
-€ 2,21
Omzet Sch.
65,87 M
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -€ 0,51
·
Rev Est: 16,82 M
| Q12025 | Q22025 | 2026-Q1 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|
| Reported | -€ 1,06 | -€ 0,85 | -€ 0,42 | -€ 0,87 | -€ 0,42 | — | — |
| Estimate | -€ 1,14 | -€ 0,89 | -€ 0,51 | -€ 1,01 | -€ 0,88 | -€ 0,51 | -€ 0,49 |
| Verrassing | +6,69% | +3,95% | +17,24% | +13,86% | +52,05% | — | — |
Growth
Rev 5Y: -9,43% · Earnings 1Y: N/A
Growth
Rev 5Y: -9,43% · Earnings 1Y: N/A| Revenue Growth (1Y) | -3,42% | Revenue Growth (3Y) | -9,18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -9,43% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -91,15% · Net Margin: -111,78%
Profitability
ROE: -91,15% · Net Margin: -111,78%| Revenue (TTM) | 83,94 M | Net Income (TTM) | -93,83 M |
| ROE | -91,15% | ROA | -29,76% |
| Gross Margin | N/A | Operating Margin | -115,09% |
| Net Margin | -111,78% | Free Cash Flow (TTM) | -44,01 M |
| ROIC | -28,20% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 4,44
Safety
D/E: N/A · Current: 4,44| Debt / Equity | N/A | Current Ratio | 4,44 |
| Interest Coverage | -8,97 | Asset Turnover | 0,27 |
| Working Capital | 153,96 M | Tangible Book Value | 126,59 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -4,30 · EV/EBITDA: N/A
Valuation
P/E: -4,30 · EV/EBITDA: N/A| P/E Ratio | -4,30 | Forward P/E | -6,59 |
| P/B Ratio | 3,19 | P/S Ratio | 4,81 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 6,12 | Fwd Earnings Yield | N/A |
| FCF Yield | -10,91% | ||
| Market Cap | 403,37 M | Enterprise Value | 365,93 M |
Per Share
EPS: -4,26 · FCF/Share: -1,52
Per Share
EPS: -4,26 · FCF/Share: -1,52| EPS (Diluted TTM) | -4,26 | Revenue / Share | 2,89 |
| FCF / Share | -1,52 | OCF / Share | -1,07 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 46,91% · CapEx/Rev: 15,53%
Efficiency
FCF Conv: 46,91% · CapEx/Rev: 15,53%| CapEx / Revenue | 15,53% | FCF Conversion | 46,91% |
| SBC-Adj. FCF | -67,77 M | Growth Momentum | 6,01 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 65,32 M | 67,64 M | 79,20 M | 86,16 M | 97,07 M |
| Net Income | -81,89 M | -116,05 M | -133,82 M | -121,76 M | -79,00 M |
| EPS (Diluted) | -3,84 | -5,48 | -6,38 | -5,91 | -3,92 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -85,35 M | -121,69 M | -137,21 M | -123,84 M | -109,57 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 106,74 M | 131,48 M | 163,52 M | 164,52 M | 174,11 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 4,59 M | 2,34 M | 2,37 M | 2,97 M | 3,33 M |
| Interest Expense | 7,68 M | 10,94 M | 5,15 M | — | — |
| Income Tax | -1,66 M | -1,74 M | 2,82 M | -433.000,0 | -28,58 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 280,73 M | 376,65 M | 462,28 M | 375,41 M | 438,79 M |
| Total Liabilities | 216,02 M | 247,84 M | 245,54 M | 54,08 M | 39,36 M |
| Shareholders' Equity | 64,72 M | 128,81 M | 216,74 M | 321,33 M | 399,43 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 32,30 M | 37,23 M | 85,39 M | 43,99 M | 57,21 M |
| Current Assets | 204,34 M | 299,85 M | 422,79 M | 311,71 M | 319,02 M |
| Current Liabilities | 48,56 M | 57,54 M | 62,79 M | 29,83 M | 36,17 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,3 | -1,5 |
| P/B | 3,2 | 1,6 |
| ROE % | -91,2 | -54,7 |
| Net Margin % | -111,8 | -41,5 |
| Rev Growth 5Y % | -9,4 | 1,7 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"ENTA","listing_kind":"stock","pathname":"/stocks/enta","exchange":"NASDAQ","country":"US"}}